Stanford, CA, United States of America

Luis R Soares

This inventor holds 2 USPTO granted patents. Top assignee: Leland Stanford Junior University. Active years: 2011-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Luis R Soares. Retrieved from https://idiyas.com/inventor/luis-r-soares

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Inventor Luis R. Soares**

Introduction

Luis R. Soares, an accomplished inventor based in Stanford, California, has made significant contributions to the field of immunology through his innovative work and inventions. With two patented inventions, he aims to tackle autoimmune and allergic inflammatory diseases, enhancing treatment options for patients in need.

Latest Patents

Soares's latest patents include groundbreaking methods and compositions that utilize a combination of low-dose interleukin-2 (IL-2) and an inhibitor of Treg IL-2R desensitization. This inventive approach is particularly aimed at treating inflammatory diseases by administering these compounds to patients in need of therapeutic intervention. His research indicates that a low dose of IL-2 is effective in stimulating regulatory T lymphocytes (Tregs) without significantly inducing effector T lymphocytes (Teffs). Furthermore, the inhibitor of IL-2R desensitization could be a small molecule or drug, such as a NEDD8 activating enzyme (NAE) inhibitor. Notably, the combination therapy is proposed to provide a synergistic effect, resulting in outcomes that surpass the effects of administering either component alone.

Another notable patent focuses on a polypeptide complex that plays a critical role in regulating cell cycle and anergy. This invention identifies the active ubiquitin E3 ligase, GRAIL, which is essential in the induction of anergy in immune cells and the regulation of cellular proliferation. The research reveals the interplay of GRAIL with Otubain isoforms, including OTUBAIN-1 and its splice variant, highlighting how these proteins modulate GRAIL's auto-ubiquitination, thus influencing immune responses.

Career Highlights

Luis R. Soares has established himself as a prominent figure at the Leland Stanford Junior University, where he contributes to advanced research in immunology. His work not only advances scientific understanding but also opens pathways for innovative treatments that could benefit patients suffering from complicated inflammatory conditions.

Collaborations

Throughout his career, Soares has collaborated with various prominent researchers, including C. Garrison Fathman. These partnerships have further enriched his research capabilities and have led to several meaningful advancements in the field of immunology.

Conclusion

Luis R. Soares exemplifies the spirit of innovation in the medical research field. Through his patented work and collaborations, he is set to make a lasting impact on the treatment of autoimmune and allergic diseases, ultimately improving the quality of life for many individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…